Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Ketamine for Pediatric Laceration Repair
NCT00451724Phase 2Completed
- Sponsor
- Rhode Island Hospital
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of ketamine in laceration (3 arms), sponsored by Rhode Island Hospital. Primary endpoints: Efficacy of sedation (OSBDR) at 30 minutes and Time to onset of sedation (Ramsay 6-point Sedation Scale) at 30 minutes. Started May 2007; status: completed.
02
Drugs
ketamine
03
Conditions
laceration
Beyond the preview
Go deeper on NCT00451724.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00451724.